Pular para o conteúdo principal
Ranking Invest

SLP - Simulations Plus, Inc.

Segmento: HealthcareSimulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, it provides population modeling and simulation contract research services; training and consulting services designed to accelerate pharmacometrics studies; and clinical-pharmacology-based consulting services in support of regulatory submissions. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

Análise Ranking Invest

Valor de Mercado
$ 374.16 Mi
IVR
0.29Índice proprietário de comparação relativa: 0,29.
IVR2
-0.09Leitura proprietária complementar: -9%.
MLL
-0.09Leitura proprietária complementar: -9%.
Último Balanço Atualizado: 3T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 139.03 Mi

Dívida Líquida

-$ 35.32 Mi

L4T

$ 8.11 Mi

MM4T

8.69%

Indicadores Básicos

ROE

5.83%

Índices de Previsibilidade

Receita Líquida

D0.08

Lucro

D0.71

Margem

D0.68

Índices de Tendência

Receita Líquida

B10.20

Lucro

D0.32

Margem

E-3.00

Índices de Endividamento

DIV/PAT

-0.25

DIV/L4T

-4.36

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.